MultiCare Institute for Research & Innovation

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation3 trials
• Coronary artery disease1 trial
• Crohn's disease1 trial
• Epilepsy1 trial
• Lung cancer1 trial
• Male hypogonadism1 trial
• Prostate cancer1 trial
• Stroke1 trial
• Triple-negative breast cancer1 trial
• Type 1 diabetes1 trial
• Ulcerative colitis1 trial

Phase

• Phase 35 trials
• Phase 41 trial

Status

• Active, not recruiting3 trials
• Completed3 trials
• Recruiting3 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Heart Rhythm Clinical and Research Solutions, LLC2 trials
• Bayer1 trial
• Eisai Inc.1 trial
• Halozyme Therapeutics1 trial
• Hoffmann-La Roche1 trial
• and 5 more

Running trials

• Recruiting

  52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

  NCT06689085· Phase 3· Halozyme Therapeutics· Source

  Contact: Director Clinical Operations, MPH, CPM

• Recruiting

  A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  NCT06100289· Phase 3· Takeda· Source

  Contact: Raghu Varier (principal investigator)

• Recruiting

  LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  NCT06216301· Phase 3· NovoCure GmbH· Source

  Contact: Stacey Macon

• Active, not recruiting

  REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry

  NCT06354777· Heart Rhythm Clinical and Research Solutions, LLC· Source

• Active, not recruiting

  A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described

  NCT04122976· Bayer· Source

• Recruiting

  Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  NCT04088071· Heart Rhythm Clinical and Research Solutions, LLC· Source

  Contact: Kari Davidson

• Active, not recruiting

  Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

  NCT03281954· Phase 3· NSABP Foundation Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Crohn's disease1 recruiting
• Lung cancer1 recruiting
• Male hypogonadism1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

  NCT05224258· Medtronic MiniMed, Inc.· Source

• Completed

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Hoffmann-La Roche· Source

• Terminated

  A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

  NCT04572243· Phase 3· Eisai Inc.· Source

• Completed

  EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

  NCT03950076· Phase 4· Population Health Research Institute· Source